Skip to main content
SpringerLink
Log in

Spending on HCV medications much higher in the US than Canada

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Shakeri A, et al. Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018. Value in Health 23: 1137-1141, No. 9, Sep 2020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spending on HCV medications much higher in the US than Canada. PharmacoEcon Outcomes News 863, 28 (2020). https://doi.org/10.1007/s40274-020-7182-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7182-x

Search

Navigation